SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased trading activity as market sentiment shifts following reports of Berkshire Hathaway's full exit from the stock, prompting a divide between those concerned by the rapid liquidation and those viewing it as a long-term accumulation opportunity. The community is actively debating whether this sell-off is a sign of structural weakness or a tactical overreaction, while focus remains fixed on the company's resilient healthcare fundamentals and recent earnings performance.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena &gt; Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

The $COCK community is actively promoting its ecosystem through a mix of high-energy social media raids and the real-world integration of their food truck venture. Investors are primarily discussing the token's passive income mechanisms and ongoing efforts to scale the brand's visibility.

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and Industrial Electronics. The SBS segment is focused on the sale of burn-in and reliability test equipment used in the back-end manufacturing processes of semiconductors. Its equipment includes burn-in systems, burn-in boards, and related equipment that is used in the testing of structural integrity of integrated circuits. The Industrial Electronics segment consists of designing, manufacturing, and distributing a range of tests, processes, and other equipment used in the manufacturing processes of customers in various industries in the consumer and industrial market. The company was founded in 1958 and is headquartered in Los Angeles, CA.

Trio-Tech International

Trio-Tech International is experiencing significant upward momentum as investors highlight its role in semiconductor reliability testing for AI and EV applications, comparing its growth and valuation favorably against sector peers. The community is actively discussing the company's recent revenue acceleration, the strategic implications of its 100% ownership of Malaysian testing operations, and the potential for a long-term re-rating as the market recognizes its role in the semiconductor supply chain.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is facing a wave of retail frustration and bearish sentiment as the stock continues to underperform compared to broader crypto market movements, leading to vocal demands for share buybacks and accountability for the leadership. While some investors remain focused on the long-term potential of the Clarity Act and the firm's Ethereum treasury strategy, the community is deeply divided between those calling for a short squeeze and those accusing management of dilution and poor execution.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as investors digest a recent $200 million equity offering, which the market appears to be absorbing as a strategic growth catalyst rather than a distress signal. The community is actively discussing the company's strong backlog growth and its pivotal role in providing power infrastructure for AI data centers, with many traders framing the recent price resilience following the offering as a sign of institutional demand.

Macy's, Inc. engages in the retail of apparel, accessories, cosmetics, home furnishings, and other consumer goods. The firm's brands include Macy's, Bloomingdale's, and Bluemercury. It offers men's, women's, and children's apparel, women's accessories, intimate apparel, shoes, cosmetics, fragrances, as well as home and miscellaneous products. The company was founded by Rowland H. Macy in 1858 and is headquartered in New York, NY.

Macy`s Inc

Macy's Inc

Macy's Inc. (M) is trending after reporting a quarterly earnings beat and raising its full-year guidance, driven by successful store revamps and strength in its luxury Bloomingdale's and Bluemercury divisions. While investors are actively discussing the potential for a share price recovery and buyout rumors, community sentiment remains mixed as some traders debate whether this momentum is a sustainable turnaround or just a temporary relief rally.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on an upcoming plenary presentation at the AUA Annual Meeting, where they anticipate positive extended follow-up data for CAN-2409 in prostate cancer. The community is actively debating the stock's potential for a premium acquisition, with many highlighting institutional interest as a signal of high-conviction in its role as a potentially practice-changing therapy.

Tema ETF Trust - Tema Space Innovators ETF

Investors are actively accumulating $NASA as a high-conviction play on the space economy, particularly driven by its direct exposure to SpaceX ahead of a highly anticipated IPO. The community is heavily focused on the ETF's strategic holdings, with many debating potential price targets while highlighting the fund's role as a concentrated vehicle for gaining access to private aerospace giants.

Superfluid is a revolutionary asset streaming and distribution protocol bringing subscriptions, salaries, vesting, and rewards to DAOs and crypto-native businesses worldwide. This is made possible by the protocol’s smart contract framework which introduces the Super Token - an extension to the ERC-20 standard enabling the transfer of value in completely novel ways.

Superfluid

Superfluid is gaining significant market attention due to its highly decentralized holder structure and anticipation surrounding potential new exchange listings beyond its current Coinbase presence. The community is actively debating the token's long-term growth potential and low market cap, with sentiment polarized between those expecting rapid appreciation and others exercising caution due to its high volatility.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is trending as investors react to a significant $176 million contract with Hydra Host for edge AI infrastructure, fueling excitement over the company's modular data center pivot. While the community is actively debating the company's ability to scale operations and meet growth targets, sentiment remains focused on whether Duos can successfully bridge the gap between legacy rail tech and high-density AI infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Karyopharm Therapeutics Q1 Earnings Call Highlights

Karyopharm Therapeutics Q1 Earnings Call Highlights...

Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Beats Revenue Estimates

Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of +14.48% and +3.34%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment

Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3...

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of +30.51% and +6.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Karyopharm to Participate at Upcoming Investor Conferences

Karyopharm to Participate at Upcoming Investor Conferences Karyopharm to Participate at Upcoming Investor Conferences PR Newswire NEWTON, Mass., May 12, 2026 NEWTON, Mass., May 12, 2026 /PRNewswire...

Karyopharm to Report First Quarter 2026 Financial Results on May 14, 2026

Karyopharm to Report First Quarter 2026 Financial Results on May 14, 2026 Karyopharm to Report First Quarter 2026 Financial Results on May 14, 2026 PR Newswire NEWTON, Mass., May 7, 2026...

Karyopharm Therapeutics (NASDAQ:KPTI) Price Target Raised to $13.00 at HC Wainwright

HC Wainwright lifted their target price on Karyopharm Therapeutics from $8.00 to $13.00 and gave the company a "buy" rating in a report on Wednesday...

Karyopharm Therapeutics (KPTI) Projected to Post Quarterly Earnings on Monday

Karyopharm Therapeutics (NASDAQ:KPTI) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at...

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Consensus Rating of "Moderate Buy" from Analysts

Karyopharm Therapeutics Inc. (NASDAQ:KPTI - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the company, MarketBeat.com...

Piper Sandler Reiterates Overweight Rating for Karyopharm Therapeutics (NASDAQ:KPTI)

Piper Sandler reaffirmed an "overweight" rating and issued a $16.00 price target (up from $8.00) on shares of Karyopharm Therapeutics in a report on Monday...

$KPTI Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$1.02 up 63.18% YoY
• Reported revenue of $35.07M up 16.83% YoY
• Karyopharm reaffirms full-year 2026 total revenue guidance of $130 million to $150 million, including U.S. XPOVIO net product revenue of $115 million to $130 million for Karyopharm.

Stocktwits

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$1.02 up 63.18% YoY
• Reported revenue of $35.07M up 16.83% YoY
• Karyopharm reaffirms full-year 2026 total revenue guidance of $130 million to $150 million, including U.S. XPOVIO net product revenue of $115 million to $130 million for Karyopharm.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A. Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008 and is headquartered in Newton, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$1.31	--	--	N/A
Q1 '26	-$1.42	-$1.24	12.50%	BEAT
Q4 '25	-$1.99	-$5.71	-186.32%	MISSED
Q3 '25	-$3.47	-$3.82	-10.23%	MISSED
Q2 '25	-$4.08	-$4.32	-5.84%	MISSED

KPTI
Karyopharm Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest KPTI News

KPTIKaryopharm Therapeutics Inc